Manohar K. Raheja - 16 May 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Reporting relationship: EVP, Research & Development
Issuer ticker: SGHT
Reported as of: 16 May 2025
Net transaction value: +$38,531
SEC form: 4
Accepted by SEC: 21 May 2025, 20:39:13 UTC
Prior SEC filing: 13 Mar 2025
Next SEC filing: 03 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Jeremy Hayden, Attorney-in-Fact for Manohar K. Raheja

Key filing fact

Manohar K. Raheja filed Form 4 for Sight Sciences, Inc. (SGHT) on 21 May 2025.

Key facts

This page summarizes Manohar K. Raheja's Form 4 filing for Sight Sciences, Inc. (SGHT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 May 2025, 20:39.

Change

Previous filing in this sequence was filed on 13 Mar 2025.
Current net transaction value: +$38,531.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002042497 Primary reporting owner

Raheja Manohar K.

Relationship: EVP, Research & Development
Address: C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK
Signature: /s/ Jeremy Hayden, Attorney-in-Fact for Manohar K. Raheja
Signature date: 21 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGHT transaction

Common Stock

Award

Transaction value: $38,531
Shares: +12,767
Change %: +8.2%
Price: $3.02
Shares after: 167,767
Date: 16 May 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), that were acquired by the Reporting Person under the Sight Sciences, Inc. 2021 Employee Stock Purchase Plan ("2021 ESPP").

Footnote F2

Reflects the price at which the shares were acquired under the 2021 ESPP, which is equal to 85% of the fair market value of the Common Stock on the last day of the offering period under the 2021 ESPP.